查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1992199

乳房健康市場：2026-2032年全球市場預測（依產品類型、牲畜類型、給藥途徑、農場規模及分銷管道分類）

Udder Health Market by Product Type, Animal Type, Application Mode, Farm Size, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，乳房健康市場價值將達到 15.1 億美元，到 2026 年將成長至 15.9 億美元，到 2032 年將達到 22.9 億美元，複合年成長率為 6.15%。

主要市場統計數據
基準年 2025 15.1億美元
預計年份：2026年 15.9億美元
預測年份 2032 22.9億美元
複合年成長率 (%) 6.15%

全面概述乳房健康趨勢，揭示產品、動物、應用、通路和農場規模之間的相互依存關係，從而影響行業優先事項。

乳房健康是各種酪農系統中生產力、動物福利和食品安全的基礎。本執行摘要整合了影響乳房健康管理的許多因素，涵蓋了不斷發展的治療手段、不斷變化的配送和農場運作動態等。旨在指南企業高管、獸醫、採購經理和農場經理了解當前的關鍵優先事項以及決定未來發展韌性的策略選擇。

合理使用抗生素、數位化人口管理以及分銷管道多元化如何重塑整個產業的產品設計、部署模式和農場層面的決策？

受三大趨勢的共同推動，乳房健康領域正經歷著一場變革：人們重新關注合理使用抗生素和預防醫學；牛健康監測的快速數位化；以及分銷模式的轉變，這些轉變在擴大產品覆蓋範圍的同時壓縮了利潤空間。這些變化正在影響水牛、乳牛和山羊養殖業中抗生素、乳頭消毒劑和疫苗的研發、定位和應用。生產者擴大採用整合擠乳間隔數據、體細胞計數和行為指標的複雜方法，這正在改變擠乳前後介入措施的時間和類型。

本研究評估了關稅對供應鏈變化和籌資策略的實際影響，這些變化和策略會影響農場層面的產品採購、商業化和採用趨勢。

近期關稅政策的變化為從世界各地採購原料的利益相關人員和依賴國際供應鏈的製造商帶來了複雜的商業環境。關稅調整不僅影響原料的採購成本，還會影響庫存策略、供應商多元化以及產品上市速度。為此，採購團隊和製造商正在重新審視其供應商組合，轉向雙重採購策略，並更加重視本地生產和本地化供應鏈，以降低風險。

基於細分市場的詳細洞察，使產品開發、監管定位和市場進入策略與牲畜種類、應用程式、分銷管道和農場規模等現實世界條件保持一致。

市場區隔為產品策略與商業性執行的協調提供了觀點。分析每種產品類型（抗菌劑、哺乳浸泡劑和疫苗）的市場情況表明，治療和預防方法需要不同的監管、配方和傳播策略。抗菌劑需要嚴格的合理使用方案和診斷支持，哺乳浸泡劑強調易用性和殘留特性，而疫苗則需要可靠的低溫運輸運輸和強力的證據支持其有效性，無論品種或哺乳階段如何。

區域洞察，包括美洲、歐洲、中東和非洲以及亞太地區的監管嚴格程度、分銷複雜性和部署管道，指導本地化工作。

地理趨勢持續決定產品創新、監管壓力和市場接受度曲線的差異。在美洲，需求模式反映了許多地區先進牛管理自動化程度的提高，以及由此帶來的數據整合干預措施更高採用率；同時，監管審查也強調抗菌劑的合理使用和可追溯性。這為整合乳頭消毒劑、疫苗接種方案和監測工具的解決方案組合創造了機遇，這些方案組合專為乳牛（在某些地區也適用於水牛群）量身定做。

競爭定位與夥伴關係趨勢：全球製造商、區域專家與服務導向模式如何重新定義產品、通路與支援策略

乳房衛生領域的競爭動態由全球動物用藥品公司、專業酪農服務供應商以及擅長區域配方研發和分銷的靈活區域性企業共同塑造。主要企業持續投資於疫苗研發和平台技術，以提高疫苗的穩定性、易用性和跨物種有效性。同時，專注於局部用藥的企業則透過改善殘留特性和皮膚健康效應，致力於解決動物福利和產品品質的難題。

具體的策略挑戰在於如何使產品創新、通路細分和供應鏈韌性與農場層面的實施和監管預期保持一致。

產業領導企業應優先採取一系列切實可行的措施，使其產品系列設計與實際應用情況、監管趨勢和不斷變化的採購管道相適應。首先，他們應將合理使用抗菌藥物（AMS）納入產品訊息和促銷計劃，透過投資診斷、培訓和用藥指導，在維持療效的同時減少不必要的抗菌藥物使用。其次，他們應加快預防性產品（例如疫苗和最佳化的乳頭消毒劑）的研發，以最大限度地減少對治療介入的依賴，並增強牛的抗病能力。

為了確保研究結果的可靠性，我們採用了嚴格的混合方法研究途徑，結合了初次訪談、實地觀察、專家檢驗和三角驗證的二手資訊。

本分析整合了混合研究方法的研究成果，結合了第一手和第二手調查，確保了分析結果的穩健性和多角度性。第一手調查包括對來自不同生產系統的行業高管、獸醫、經銷商和牛管理人員進行結構化檢驗，並輔以專家小組的驗證，以檢驗主題結論和區域差異。實地考察和產品使用觀察則提供了有關大、中、小規模農場實際應用方法和現場限制的背景資訊。

策略挑戰的整合，重點在於預防、數位整合、通路差異化和供應鏈韌性，這是改善乳房健康的支柱。

總之，乳房健康管理方法正從臨時性治療轉向綜合預防、數位化管理和彈性供應鏈模式。這種轉變要求製造商和銷售管道合作夥伴重新思考產品設計、證據收集和商業性合作，並適用於包括水牛、乳牛和山羊在內的多種牲畜。無論是擠乳前或擠乳後，給藥方法對於成功實施都至關重要，必須在產品配方和終端使用者培訓中加以考慮。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：乳房健康市場：依產品類型分類

  • 抗菌劑
  • 乳頭消毒劑
  • 疫苗

第9章：乳房健康市場：依動物類型分類

  • 水牛
  • 乳牛
  • 山羊

第10章：乳房健康市場應用方法

  • 擠乳後
  • 擠乳前

第11章 按農場規模分類的乳房健康市場

  • 大型農場
  • 中型農場
  • 小規模農場

第12章：乳房健康市場：依分銷管道分類

  • 線上
  • 離線

第13章 乳房健康市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 乳房健康市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 乳房健康市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國乳房健康市場

第17章：中國乳房健康市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ABS Global, Inc.
  • Afimilk Ltd.
  • AgriLabs, Ltd.
  • Ariake Japan Co., Ltd.
  • Boehringer Ingelheim Vetmedica, Inc.
  • BouMatic LLC
  • Ceva Sante Animale
  • Dairy Master Inc.
  • DeLaval International AB
  • Elanco Animal Health Incorporated
  • GEA Group AG
  • IDEXX Laboratories, Inc.
  • ImmuCell Corporation
  • Merck & Co., Inc.
  • Milk Specialties Global, Inc.
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Performance Health, LLC
  • SCR Dairy, Inc.
  • Udder Tech, Inc.
  • Vetoquinol SA
  • Virbac Corporation
  • Westfalia Dairy Systems, Inc.
  • Zoetis Inc.
Product Code: MRR-6D2B1EBFE1B9

The Udder Health Market was valued at USD 1.51 billion in 2025 and is projected to grow to USD 1.59 billion in 2026, with a CAGR of 6.15%, reaching USD 2.29 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.51 billion
Estimated Year [2026] USD 1.59 billion
Forecast Year [2032] USD 2.29 billion
CAGR (%) 6.15%

A comprehensive orientation to udder health dynamics that clarifies product, animal, application, channel, and farm-size interdependencies shaping industry priorities

The health of the mammary gland is foundational to productivity, animal welfare, and food safety across diverse dairy systems. This executive summary synthesizes the multifaceted forces shaping udder health management, from evolving therapeutic tools to shifting distribution and farm operational dynamics. It is designed to orient senior executives, veterinarians, procurement leaders, and farm operators to the priorities that matter today and the strategic choices that will determine resilience going forward.

As the industry moves toward more data-driven herd management and heightened regulatory scrutiny, understanding product categories such as antimicrobials, teat dips, and vaccines in the context of animal types including buffalo, dairy cows, and goats becomes essential. Moreover, application modes that distinguish post-milking from pre-milking protocols interact with distribution realities across online, pharmacy, and veterinary channels and must be aligned to the needs of large, medium, and small farms. This introduction frames the subsequent analysis and clarifies how interdependencies among product innovation, channel transformation, and on-farm behavior create both risks and opportunities for stakeholders across the value chain.

How antimicrobial stewardship, digital herd monitoring, and channel diversification are reshaping product design, adoption patterns, and farm-level decision-making across the sector

The landscape for udder health is undergoing transformative shifts driven by three convergent trends: renewed emphasis on antimicrobial stewardship and preventive care, rapid digitization of herd health monitoring, and changing distribution models that expand access while compressing margins. These shifts affect how antimicrobials, teat dips, and vaccines are developed, positioned, and adopted across buffalo, dairy cows, and goats. Producers are increasingly adopting precision approaches that integrate milking-interval data, somatic cell counts, and behavioral indicators, thereby altering the timing and type of interventions applied pre-milking and post-milking.

Concurrently, distribution channels are diversifying: online channels are enabling remote procurement and subscription models, pharmacies remain vital for over-the-counter and professional advice-led sales, and veterinary distributors continue to anchor institutional supply for herd-level programs. These channel evolutions interact with farm scale: large farms are early adopters of integrated monitoring and automated application systems, medium farms are balancing cost and capability, and small farms prioritize affordability and simplicity. Collectively, these shifts are accelerating product differentiation-vaccines and teat dips designed for ease of use and regulatory compliance are moving from optional to core elements of herd health programs-while reshaping relationships between manufacturers, distributors, and on-farm decision-makers.

Assessing the practical repercussions of tariff-induced supply chain shifts and procurement strategies that impact product sourcing, commercialization, and farm-level adoption dynamics

Recent tariff policy changes have created a complex operating environment for stakeholders who source inputs globally and for manufacturers that rely on international supply chains. Tariff adjustments affect not only landed input costs but also inventory strategies, supplier diversification, and the cadence of product launches. In response, procurement teams and manufacturers have recalibrated vendor portfolios, moved to dual-sourcing strategies, and increased focus on local manufacturing or regionalized supply to mitigate exposure.

For product categories such as antimicrobials, teat dips, and vaccines, increased import duties on finished goods or raw materials can lengthen lead times and incentivize substitution toward locally produced formulations and application technologies. This shift influences adoption across animal types including buffalo, dairy cows, and goats, where regional consumption patterns and species-specific product requirements diverge. Application mode considerations-whether an intervention is administered pre-milking or post-milking-become operational levers as farms look to optimize labor and compliance under new cost structures.

Distribution channels also adapt: online platforms provide comparative pricing and alternative sourcing options, pharmacies may expand their portfolios to include more locally manufactured items, and veterinary distributors often take on more inventory risk to maintain service levels. Farm-size dynamics further complicate the picture. Large farms can absorb short-term cost increases through scale economies or negotiate direct supply arrangements, medium farms may face tighter operational trade-offs, and small farms may delay or forego non-essential interventions unless supported by extension services or bundled value propositions. Consequently, tariff-driven change is not a transient shock but a catalyst for longer-term structural adjustments across supply chains, commercialization models, and on-farm practices.

Deep segmentation-driven insights that align product development, regulatory positioning, and go-to-market strategies to the practical realities of species, application routines, channels, and farm scales

Segmentation provides the lens through which product strategies and commercial execution must be aligned. When the market is examined by product type across antimicrobials, teat dips, and vaccines, it becomes clear that therapeutic and preventive approaches require distinct regulatory, formulation, and communication strategies. Antimicrobials demand rigorous stewardship programs and diagnostic support; teat dips emphasize ease of application and residue profiles; vaccines require cold-chain reliability and strong evidence of efficacy across breeds and lactation stages.

Looking at animal type segmentation across buffalo, dairy cows, and goats reveals significant biological and management differences that shape product performance and value propositions. Buffalo herds often raise considerations around thicker teat skin and region-specific pathogens, dairy cows present high-volume production dynamics with intense milking schedules, and goats present smaller-flock management realities with divergent dosing practices. Application mode segmentation into post-milking and pre-milking practices underscores how timing, labor intensity, and compatibility with milking equipment influence adoption and compliance.

Distribution channel segmentation across online, pharmacy, and veterinary distributors highlights differing buyer journeys and trust frameworks; online channels prioritize convenience and price transparency, pharmacies blend retail accessibility with professional advice, and veterinary distributors offer bundled services and programmatic engagement. Finally, farm size segmentation across large farms, medium farms, and small farms illustrates distinct commercial approaches: tailored service-level agreements and integration with herd management software for larger operations, cost-effective package offerings for medium operations, and simplified, education-led models for smaller farms. Taken together, these segmentation insights guide product roadmaps, pricing strategies, and channel investments that resonate with the practical realities of each customer cohort.

Regional intelligence that maps regulatory rigor, distribution complexity, and adoption pathways across Americas, Europe Middle East & Africa, and Asia-Pacific to guide localization

Geographic dynamics continue to define where product innovation, regulatory pressure, and adoption curves diverge. In the Americas, demand patterns reflect advanced herd automation in many regions and a correspondingly higher uptake of data-integrated interventions, while regulatory revisions emphasize antimicrobial stewardship and traceability. This creates opportunities for solution bundles that combine teat dips, vaccination schedules, and monitoring tools tailored to dairy cows and, in specific locales, buffalo herds.

Across Europe, Middle East & Africa, the landscape is heterogeneous: stringent European regulations push manufacturers toward low-residue formulations and rigorous vaccine dossiers, whereas several markets in the Middle East & Africa prioritize affordability, cold-chain robustness, and education-driven distribution to reach smallholder and pastoral systems. These regional differences affect product design and channel strategies differently for buffalo, dairy cows, and goats. Meanwhile, Asia-Pacific exhibits rapid modernization in many supply chains, with intensive integration of online procurement platforms and expanded veterinary distributor networks; here, the balance between high-volume dairy cow operations and traditional smallholder goat and buffalo systems necessitates flexible pack sizes and scalable training programs.

Across regions, the interplay between application modes, distribution channels, and farm sizes shapes the most effective commercial propositions. For example, post-milking solutions paired with digital reminders and subscription-based online replenishment resonate strongly with automated large farms, while pre-milking educational campaigns through pharmacies and veterinary distributors are more effective in regions with a high share of small to medium farms. Regional intelligence therefore informs not only product localization but also how manufacturers prioritize regulatory filings, cold-chain investments, and partner enablement for dealerships and pharmacies.

Competitive positioning and partnership dynamics showing how global manufacturers, regional specialists, and service-oriented models are redefining product, channel, and support strategies

Competitive dynamics in udder health are shaped by a mix of global animal-health firms, specialized dairy-service providers, and nimble regional players that excel at localized formulations and distribution. Leading manufacturers continue to invest in vaccine R&D and platform technologies that improve stability, ease of administration, and cross-species efficacy, while companies focused on topical treatments are innovating around residue profiles and skin health benefits to address both welfare and product-quality concerns.

Partnerships between pharmaceutical manufacturers and veterinary distributor networks are increasing as companies seek to convert product sales into programmatic herd-level services. Service-oriented models combine technical training, digital monitoring, and bundled replenishment to enhance customer retention, particularly among larger farms that value integrated solutions. At the regional level, specialized firms that understand buffalo and goat production systems are critical partners for commercializing species-specific products and for navigating local regulatory pathways.

New entrants are differentiating through targeted value propositions: subscription delivery models via online channels that simplify procurement for remote farms, pharmacy partnerships that enhance last-mile access and advice, and co-development agreements with farm management software providers to embed prophylactic protocols within operational workflows. Collectively, these competitive moves are reshaping pricing, go-to-market partnerships, and expectations for post-sale service and technical support.

Concrete strategic imperatives to align product innovation, channel segmentation, and supply-chain resilience with farm-level adoption and regulatory expectations

Industry leaders should prioritize a set of actionable responses that align portfolio design with on-farm realities, regulatory trends, and evolving procurement channels. First, integrate antimicrobial stewardship into product messaging and commercial programs by investing in diagnostics, training, and dosing guidance that reduce unnecessary use while protecting therapeutic efficacy. Second, accelerate development of preventive offerings-such as vaccines and optimized teat dip formulations-that minimize reliance on curative treatments and support herd resilience.

Third, adopt channel differentiation strategies that tailor product packs, pricing, and service levels to online buyers, pharmacy customers, and veterinary distributors. For large farms, design bundled solutions that integrate with herd management systems and offer performance guarantees; for medium and small farms, prioritize affordability, simplicity, and strong in-field support. Fourth, build supply-chain resilience through supplier diversification, regional manufacturing partnerships, and inventory strategies that mitigate tariff and logistics shocks while preserving cold-chain integrity for vaccines.

Fifth, invest in evidence-generation-real-world studies, region-specific efficacy data, and case studies-that enable faster adoption and facilitate regulatory approvals. Sixth, strengthen commercial models by piloting subscription and replenishment services and by training distributor and pharmacy networks to act as trusted advisors. Finally, commit to transparent sustainability and welfare narratives that articulate product benefits in terms of milk quality, animal health outcomes, and compliance with evolving regulatory expectations.

A rigorous mixed-methods research approach combining primary interviews, field observations, expert validation, and triangulated secondary intelligence to ensure robust insights

This analysis synthesizes findings from a mixed-methods research design combining primary and secondary evidence to ensure robust, triangulated insights. Primary research included structured interviews with industry executives, veterinarians, distributors, and herd managers across a range of production systems, supplemented by expert panels that validated thematic conclusions and regional nuances. Field visits and product-use observations provided context on application-mode realities and on-farm constraints for large, medium, and small operations.

Secondary research encompassed regulatory documents, peer-reviewed literature on mastitis control and vaccine efficacy, technical product literature, and publicly available company disclosures to map competitive positioning and innovation trajectories. Data triangulation techniques ensured consistency across sources and highlighted areas where further primary research is warranted. Quality assurance protocols included expert review of draft findings, cross-validation of claims against multiple data sources, and sensitivity checks for assertions related to supply-chain impacts and tariff adjustments. The methodology emphasizes transparency and reproducibility so that stakeholders can assess the provenance of insights and request targeted follow-on analyses where needed.

Synthesis of strategic imperatives that underscore prevention, digital integration, channel differentiation, and supply resilience as the pillars of udder health progress

In conclusion, the udder health agenda is shifting from episodic treatment toward integrated prevention, digital-enabled management, and resilient supply models. This evolution requires manufacturers and channel partners to rethink product design, evidence-generation, and commercial engagement across varied animal types such as buffalo, dairy cows, and goats. Application modes, whether pre-milking or post-milking, remain critical levers for adoption and must be accounted for in both product formulation and end-user training.

Distribution strategies that differentiate online convenience, pharmacy accessibility, and veterinary distributor services will determine how effectively solutions reach large, medium, and small farms. Meanwhile, tariff-induced supply-chain dynamics are prompting strategic changes in sourcing, regional manufacturing, and inventory management that will have lasting implications for pricing and availability. By aligning portfolios to segmentation realities and regional nuances, and by investing in stewardship, evidence, and service models, stakeholders can position themselves to deliver measurable improvements in animal welfare, milk quality, and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Udder Health Market, by Product Type

  • 8.1. Antimicrobials
  • 8.2. Teat Dips
  • 8.3. Vaccines

9. Udder Health Market, by Animal Type

  • 9.1. Buffalo
  • 9.2. Dairy Cows
  • 9.3. Goats

10. Udder Health Market, by Application Mode

  • 10.1. Post-Milking
  • 10.2. Pre-Milking

11. Udder Health Market, by Farm Size

  • 11.1. Large Farms
  • 11.2. Medium Farms
  • 11.3. Small Farms

12. Udder Health Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Udder Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Udder Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Udder Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Udder Health Market

17. China Udder Health Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ABS Global, Inc.
  • 18.6. Afimilk Ltd.
  • 18.7. AgriLabs, Ltd.
  • 18.8. Ariake Japan Co., Ltd.
  • 18.9. Boehringer Ingelheim Vetmedica, Inc.
  • 18.10. BouMatic LLC
  • 18.11. Ceva Sante Animale
  • 18.12. Dairy Master Inc.
  • 18.13. DeLaval International AB
  • 18.14. Elanco Animal Health Incorporated
  • 18.15. GEA Group AG
  • 18.16. IDEXX Laboratories, Inc.
  • 18.17. ImmuCell Corporation
  • 18.18. Merck & Co., Inc.
  • 18.19. Milk Specialties Global, Inc.
  • 18.20. Neogen Corporation
  • 18.21. Norbrook Laboratories Limited
  • 18.22. Performance Health, LLC
  • 18.23. SCR Dairy, Inc.
  • 18.24. Udder Tech, Inc.
  • 18.25. Vetoquinol SA
  • 18.26. Virbac Corporation
  • 18.27. Westfalia Dairy Systems, Inc.
  • 18.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL UDDER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UDDER HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL UDDER HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL UDDER HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UDDER HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL UDDER HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES UDDER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA UDDER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UDDER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL UDDER HEALTH MARKET SIZE, BY ANTIMICROBIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL UDDER HEALTH MARKET SIZE, BY ANTIMICROBIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL UDDER HEALTH MARKET SIZE, BY ANTIMICROBIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL UDDER HEALTH MARKET SIZE, BY TEAT DIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL UDDER HEALTH MARKET SIZE, BY TEAT DIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL UDDER HEALTH MARKET SIZE, BY TEAT DIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UDDER HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL UDDER HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL UDDER HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UDDER HEALTH MARKET SIZE, BY BUFFALO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UDDER HEALTH MARKET SIZE, BY BUFFALO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UDDER HEALTH MARKET SIZE, BY BUFFALO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL UDDER HEALTH MARKET SIZE, BY DAIRY COWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL UDDER HEALTH MARKET SIZE, BY DAIRY COWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UDDER HEALTH MARKET SIZE, BY DAIRY COWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UDDER HEALTH MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UDDER HEALTH MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL UDDER HEALTH MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL UDDER HEALTH MARKET SIZE, BY POST-MILKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL UDDER HEALTH MARKET SIZE, BY POST-MILKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL UDDER HEALTH MARKET SIZE, BY POST-MILKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL UDDER HEALTH MARKET SIZE, BY PRE-MILKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL UDDER HEALTH MARKET SIZE, BY PRE-MILKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL UDDER HEALTH MARKET SIZE, BY PRE-MILKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL UDDER HEALTH MARKET SIZE, BY LARGE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UDDER HEALTH MARKET SIZE, BY LARGE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UDDER HEALTH MARKET SIZE, BY LARGE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UDDER HEALTH MARKET SIZE, BY MEDIUM FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL UDDER HEALTH MARKET SIZE, BY MEDIUM FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL UDDER HEALTH MARKET SIZE, BY MEDIUM FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL UDDER HEALTH MARKET SIZE, BY SMALL FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL UDDER HEALTH MARKET SIZE, BY SMALL FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL UDDER HEALTH MARKET SIZE, BY SMALL FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL UDDER HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL UDDER HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UDDER HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL UDDER HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL UDDER HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL UDDER HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL UDDER HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS UDDER HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA UDDER HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL UDDER HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. GCC UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. GCC UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 107. GCC UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. G7 UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. G7 UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 124. G7 UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. G7 UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. NATO UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 130. NATO UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. NATO UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL UDDER HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES UDDER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA UDDER HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA UDDER HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA UDDER HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA UDDER HEALTH MARKET SIZE, BY APPLICATION MODE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA UDDER HEALTH MARKET SIZE, BY FARM SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA UDDER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)